학술논문
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
Document Type
Article
Author
Chu, Q.; Perrone, F.; Piccirillo, M.C.; Gargiulo, P.; Morabito, A.; Greillier, L.; Tu, W.; Tu, D.; Sederias, J.; Brown-Walker, P.; Seymour, L.; Grosso, F.; Delfanti, S.; Lo Russo, G.; Florescu, M.; Mencoboni, M.; Cecere, F.L.; Ceresoli, G.L.; Dawe, D.E.; Zucali, P.A.; Pagano, M.; Goffin, J.R.; Sanchez, M.L.; Gridelli, C.; Zalcman, G.; Quantin, X.; Westeel, V.; Lee, C.W.; Leighl, N.; Tsao, M.-S.; Bradbury, P.; Luo, Y.; Lantuejoul, S.; Scherpereel, A.; Laurie, S.A.
Source
In: The Lancet . (The Lancet, 16 December 2023, 402(10419):2295-2306)
Subject
Language
English
ISSN
1474547X
01406736
01406736